Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
Ibutilide promptly restored sinus rhythm on two occasions in an elderly patient with AF and rapid ventricular response associated with the WPW syndrome. As a selective Class III antiarrhythmic agent that prolongs cardiac refractoriness, ibutilide offers an alternative effective therapy for rapid termination of AF in WPW.
Varriale
P
P
Cardiology Division, Cabrini Medical Center, New York, New York 10003, USA.
Sedighi
A
A
Mirzaietehrane
M
M
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D017115:Catheter Ablation; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology; D006339:Heart Rate; D006801:Humans; D007262:Infusions, Intravenous; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications* / Q000503:physiopathology / Q000601:surgery
D000889:Anti-Arrhythmia Agents; D013449:Sulfonamides; C067192:ibutilide